Data protection Impressum

Healthcare

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

Inaugurated in May 2025, the PULSE Innovation Center in Cheseaux-sur-Lausanne is emerging as a flagship site for life sciences and high-tech companies in Western Switzerland, offering modular infrastructure, shared services, and a unique environment for collaboration and growth.

PULSE, a new era for innovation in Western Switzerland

21 May 2025

Swiss Medical Network has become the first healthcare provider in Western Europe to join the prestigious Mayo Clinic Care Network. The collaboration strengthens Switzerland’s position as a hub for advanced medical innovation and international clinical partnerships.

Swiss Medical Network joins Mayo Clinic Care Network to elevate patient care

13 May 2025

Neuchâtel’s CSEM is playing a central role in the QUESTIONED project, an initiative aiming to reduce postoperative delirium (POD) in elderly patients through real-time brain activity monitoring during anesthesia.

CSEM technology supports breakthrough in EEG monitoring to reduce postoperative delirium

12 May 2025

The Lausanne Region Trophy at the 23rd Prix Entreprendre Lausanne Région (PERL) ceremony has been awarded to Carewell, a Pully-based start-up optimizing healthcare staffing through a digital platform that merges technological and social innovation.

Carewell wins 2025 PERL Award for innovation in healthcare staffing

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: building resilience through global alliances

6 May 2025

Four innovative Geneva-based start-ups have received funding from the FONGIT Innovation Fund (FIF), highlighting the canton’s continued support for impactful technologies in life sciences and sustainable mobility.

Geneva-based start-ups awarded FIF funding to accelerate innovation in health and mobility

5 May 2025

Neuchâtel health tech company Aktiia has announced its rebranding to Hilo, alongside the closing of a USD 42 million Series B funding round. The new capital will support the international growth of its cuffless blood pressure monitoring platform and further product development.

Aktiia becomes Hilo and raises USD 42 million to accelerate global expansion

5 May 2025

University of Bern researchers develop ultrasound-powered method to clean stents non-invasively, improving patient care and reducing hospital costs.

University of Bern researchers pioneer ultrasound-based method to clean implanted medical devices

5 May 2025

1 2 3 4 5 6 7 8 9 … 21